Precose (acarbose) reduces the risk of heart disease in patients with "pre-diabetes"

New evidence suggests Precose (acarbose) reduces the risk of heart disease in patients with "pre-diabetes."

These patients have impaired glucose tolerance and are at risk for developing both diabetes and heart disease.

Precose seems to help. But you need to treat 20 patients for 3 years to prevent one case of hypertension...or 40 patients to prevent one case of heart disease.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote